RxDoctor Payments Data

Robert Schwartz

Cardiovascular Disease · Minneapolis, MNNPI 1750341889

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $492,642 of the $501,793 with a category attached, or 98.2%. Integer Holdings Corporation accounts for 98.2% of it on its own, with 5 other manufacturers making up the rest. Among cardiovascular disease clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$501,793in general payments, 2019–2025

Across 24 payments — averaging $20,908 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integer Holdings Corporation$493K
  • Boston Scientific$8K
  • Medtronic$400
  • Canon Medical Informatics, Inc.$148
  • Siemens Medical Solutions USA, Inc.$80
  • Amgen$27

What the payments were for

  • Royalty or licence$492,64298%
  • Consulting fees$7,2001%
  • Speaking & faculty fees$4000%
  • Travel & lodging$5600%
  • Food & beverage$9920%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$501,793 in reported general payments places this provider in the 95th percentile of 451 cardiovascular disease providers in Minnesota.

See all cardiovascular disease providers in Minnesota

Other cardiovascular disease in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →